A citation-based method for searching scientific literature

Junsong Zhou, Aizhen Yang, Yucan Wang, Fengwu Chen, Zhenzhen Zhao, Viralkumar Davra, Katsue Suzuki-Inoue, Yukio Ozaki, Raymond B Birge, Qingxian Lu, Yi Wu. Cell Commun Signal 2018
Times Cited: 13







List of co-cited articles
112 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity.
Alisa B Lee-Sherick, Kristen M Jacobsen, Curtis J Henry, Madeline G Huey, Rebecca E Parker, Lauren S Page, Amanda A Hill, Xiaodong Wang, Stephen V Frye, H Shelton Earp,[...]. JCI Insight 2018
40
38

Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
Wen-I Tsou, Khanh-Quynh N Nguyen, Daniel A Calarese, Scott J Garforth, Anita L Antes, Sergey V Smirnov, Steve C Almo, Raymond B Birge, Sergei V Kotenko. J Biol Chem 2014
145
38

The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.
Douglas K Graham, Deborah DeRyckere, Kurtis D Davies, H Shelton Earp. Nat Rev Cancer 2014
413
38

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression.
Canan Kasikara, Sushil Kumar, Stanley Kimani, Wen-I Tsou, Ke Geng, Viralkumar Davra, Ganapathy Sriram, Connor Devoe, Khanh-Quynh N Nguyen, Anita Antes,[...]. Mol Cancer Res 2017
76
30

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis.
Rebecca S Cook, Kristen M Jacobsen, Anne M Wofford, Deborah DeRyckere, Jamie Stanford, Anne L Prieto, Elizabeth Redente, Melissa Sandahl, Debra M Hunter, Karen E Strunk,[...]. J Clin Invest 2013
112
30

A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation.
Susan Sather, Karla D Kenyon, Jerry B Lefkowitz, Xiayuan Liang, Brian C Varnum, Peter M Henson, Douglas K Graham. Blood 2007
223
30

T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response.
Eugenio A Carrera Silva, Pamela Y Chan, Leonel Joannas, Andrea E Errasti, Nicola Gagliani, Lidia Bosurgi, Maurice Jabbour, Anthony Perry, Faye Smith-Chakmakova, Daniel Mucida,[...]. Immunity 2013
119
23

TAM receptor signaling in immune homeostasis.
Carla V Rothlin, Eugenio A Carrera-Silva, Lidia Bosurgi, Sourav Ghosh. Annu Rev Immunol 2015
265
23

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer.
Zhenfeng Zhang, Jae Cheol Lee, Luping Lin, Victor Olivas, Valerie Au, Thomas LaFramboise, Mohamed Abdel-Rahman, Xiaoqi Wang, Alan D Levine, Jin Kyung Rho,[...]. Nat Genet 2012
867
23

The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Magdalena Paolino, Axel Choidas, Stephanie Wallner, Blanka Pranjic, Iris Uribesalgo, Stefanie Loeser, Amanda M Jamieson, Wallace Y Langdon, Fumiyo Ikeda, Juan Pablo Fededa,[...]. Nature 2014
291
23


TAM receptors are pleiotropic inhibitors of the innate immune response.
Carla V Rothlin, Sourav Ghosh, Elina I Zuniga, Michael B A Oldstone, Greg Lemke. Cell 2007
705
23

Galectin-3 is a new MerTK-specific eat-me signal.
Nora B Caberoy, Gabriela Alvarado, Jo-Lawrence Bigcas, Wei Li. J Cell Physiol 2012
120
23

Cloning and mRNA expression analysis of a novel human protooncogene, c-mer.
D K Graham, T L Dawson, D L Mullaney, H R Snodgrass, H S Earp. Cell Growth Differ 1994
262
23

Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase.
Philip L Cohen, Roberto Caricchio, Valsamma Abraham, Todd D Camenisch, J Charles Jennette, Robert A S Roubey, H Shelton Earp, Glenn Matsushima, Elizabeth A Reap. J Exp Med 2002
481
23

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
R M A Linger, R A Cohen, C T Cummings, S Sather, J Migdall-Wilson, D H G Middleton, X Lu, A E Barón, W A Franklin, D T Merrick,[...]. Oncogene 2013
142
23

MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system.
Justus M Huelse, Diana M Fridlyand, Shelton Earp, Deborah DeRyckere, Douglas K Graham. Pharmacol Ther 2020
23
23

Small Molecule Inhibition of MERTK Is Efficacious in Non-Small Cell Lung Cancer Models Independent of Driver Oncogene Status.
Christopher T Cummings, Weihe Zhang, Kurtis D Davies, Gregory D Kirkpatrick, Dehui Zhang, Deborah DeRyckere, Xiaodong Wang, Stephen V Frye, H Shelton Earp, Douglas K Graham. Mol Cancer Ther 2015
39
23

Phagocytosis and clearance of apoptotic cells is mediated by MER.
R S Scott, E J McMahon, S M Pop, E A Reap, R Caricchio, P L Cohen, H S Earp, G K Matsushima. Nature 2001
864
23

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy.
Marka R Crittenden, Jason Baird, David Friedman, Talicia Savage, Lauren Uhde, Alejandro Alice, Benjamin Cottam, Kristina Young, Pippa Newell, Cynthia Nguyen,[...]. Oncotarget 2016
63
23

TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis.
Jonathan H M van der Meer, Tom van der Poll, Cornelis van 't Veer. Blood 2014
180
23

Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis.
Nora B Caberoy, Yixiong Zhou, Wei Li. EMBO J 2010
115
23

Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
Heather M Seitz, Todd D Camenisch, Greg Lemke, H Shelton Earp, Glenn K Matsushima. J Immunol 2007
274
23

The Pros1/Tyro3 axis protects against periodontitis by modulating STAT/SOCS signalling.
Lei Jiang, Xiao Qing Chen, Ming Jing Gao, Wai Lee, Jie Zhou, Yun Fu Zhao, Guo Dong Wang. J Cell Mol Med 2019
12
16

Tyro3 Modulates Mertk-Associated Retinal Degeneration.
Douglas Vollrath, Douglas Yasumura, Gillie Benchorin, Michael T Matthes, Wei Feng, Natalie M Nguyen, Cecilia D Sedano, Melissa A Calton, Matthew M LaVail. PLoS Genet 2015
36
15

Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer.
R B Birge, S Boeltz, S Kumar, J Carlson, J Wanderley, D Calianese, M Barcinski, R A Brekken, X Huang, J T Hutchins,[...]. Cell Death Differ 2016
351
15

Platelet membrane proteomics: a novel repository for functional research.
Urs Lewandrowski, Stefanie Wortelkamp, Katharina Lohrig, René P Zahedi, Dirk A Wolters, Ulrich Walter, Albert Sickmann. Blood 2009
92
15

The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways.
Julia M Burkhart, Marc Vaudel, Stepan Gambaryan, Sonja Radau, Ulrich Walter, Lennart Martens, Jörg Geiger, Albert Sickmann, René P Zahedi. Blood 2012
481
15

Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance.
Miles A Miller, Madeleine J Oudin, Ryan J Sullivan, Stephanie J Wang, Aaron S Meyer, Hyungsoon Im, Dennie T Frederick, Jenny Tadros, Linda G Griffith, Hakho Lee,[...]. Cancer Discov 2016
112
15

Phosphatidylinositol transfer protein-α in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis.
Liang Zhao, Chelsea L Thorsheim, Aae Suzuki, Timothy J Stalker, Sang H Min, Lurong Lian, Gregory D Fairn, Shamshad Cockcroft, Amy Durham, Sriram Krishnaswamy,[...]. Nat Commun 2017
15
15

Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis.
A Angelillo-Scherrer, P de Frutos, C Aparicio, E Melis, P Savi, F Lupu, J Arnout, M Dewerchin, M Hoylaerts, J Herbert,[...]. Nat Med 2001
333
15

A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6b-B, a novel immunoreceptor tyrosine-based inhibitory motif protein.
Yotis A Senis, Michael G Tomlinson, Angel García, Stephanie Dumon, Victoria L Heath, John Herbert, Stephen P Cobbold, Jennifer C Spalton, Sinem Ayman, Robin Antrobus,[...]. Mol Cell Proteomics 2007
114
15

The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis.
B R Branchford, T J Stalker, L Law, G Acevedo, S Sather, C Brzezinski, K M Wilson, K Minson, A B Lee-Sherick, P Davizon-Castillo,[...]. J Thromb Haemost 2018
17
15

New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis.
Sara Pagani, Mattia Bellan, Daniele Mauro, Luigi Mario Castello, Gian Carlo Avanzi, Myles J Lewis, Pier Paolo Sainaghi, Costantino Pitzalis, Alessandra Nerviani. Dis Markers 2020
15
15

TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting.
Marlies J W Peeters, Anne Rahbech, Per Thor Straten. Cancer Immunol Immunother 2020
18
15

The Emerging Role of TYRO3 as a Therapeutic Target in Cancer.
Sherri K Smart, Eleana Vasileiadi, Xiaodong Wang, Deborah DeRyckere, Douglas K Graham. Cancers (Basel) 2018
41
15

Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis.
Gisela Ruiz-Heiland, Yi Zhao, Anja Derer, Tobias Braun, Klaus Engelke, Elena Neumann, Ulf Mueller-Ladner, Yi Liu, Jochen Zwerina, Georg Schett. Ann Rheum Dis 2014
18
15

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells.
Marlies J W Peeters, Donata Dulkeviciute, Arianna Draghi, Cathrin Ritter, Anne Rahbech, Signe K Skadborg, Tina Seremet, Ana Micaela Carnaz Simões, Evelina Martinenaite, Hólmfridur R Halldórsdóttir,[...]. Cancer Immunol Res 2019
25
15

Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer.
Lidia Bosurgi, Jochem H Bernink, Victor Delgado Cuevas, Nicola Gagliani, Leonel Joannas, Edward T Schmid, Carmen J Booth, Sourav Ghosh, Carla V Rothlin. Proc Natl Acad Sci U S A 2013
96
15

Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
Khanh-Quynh N Nguyen, Wen-I Tsou, Daniel A Calarese, Stanley G Kimani, Sukhwinder Singh, Shelly Hsieh, Yongzhang Liu, Bin Lu, Yi Wu, Scott J Garforth,[...]. J Biol Chem 2014
60
15


Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer.
G Mudduluru, P Ceppi, R Kumarswamy, G V Scagliotti, M Papotti, H Allgayer. Oncogene 2011
197
15


AXL mediates resistance to cetuximab therapy.
Toni M Brand, Mari Iida, Andrew P Stein, Kelsey L Corrigan, Cara M Braverman, Neha Luthar, Mahmoud Toulany, Parkash S Gill, Ravi Salgia, Randall J Kimple,[...]. Cancer Res 2014
132
15

Sunitinib activates Axl signaling in renal cell cancer.
Johannes C van der Mijn, Henk J Broxterman, Jaco C Knol, Sander R Piersma, Richard R De Haas, Henk Dekker, Thang V Pham, Victor W Van Beusechem, Balazs Halmos, James W Mier,[...]. Int J Cancer 2016
28
15

Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.
Kathleen F Ludwig, Wenting Du, Noah B Sorrelle, Katarzyna Wnuk-Lipinska, Mary Topalovski, Jason E Toombs, Victoria H Cruz, Shinichi Yabuuchi, N V Rajeshkumar, Anirban Maitra,[...]. Cancer Res 2018
84
15

AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells.
Maria L Lotsberg, Katarzyna Wnuk-Lipinska, Stéphane Terry, Tuan Zea Tan, Ning Lu, Laura Trachsel-Moncho, Gro V Røsland, Muntequa I Siraji, Monica Hellesøy, Austin Rayford,[...]. J Thorac Oncol 2020
42
15

Biology of the TAM receptors.
Greg Lemke. Cold Spring Harb Perspect Biol 2013
342
15

Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase.
Martina Ott, Ulrike M Litzenburger, Felix Sahm, Katharina J Rauschenbach, Ruxandra Tudoran, Christian Hartmann, Victor E Marquez, Andreas von Deimling, Wolfgang Wick, Michael Platten. PLoS One 2012
37
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.